CUSIP

Rackspace Technology Announces Increase to Late Exchange Consideration for Exchange Offer Relating to its 3.50% First-Priority Senior Secured Notes due 2028

Retrieved on: 
Friday, March 29, 2024

Holders of Existing Secured Notes that are accepted for exchange pursuant to the Exchange Offer will be entitled to receive accrued and unpaid interest in cash on the Existing Secured Notes exchanged for Exchange Notes up to, but excluding, March 12, 2024.

Key Points: 
  • Holders of Existing Secured Notes that are accepted for exchange pursuant to the Exchange Offer will be entitled to receive accrued and unpaid interest in cash on the Existing Secured Notes exchanged for Exchange Notes up to, but excluding, March 12, 2024.
  • Interest on the Exchange Notes will accrue from March 12, 2024, with the first interest payment occurring on August 15, 2024.
  • Consummation of the Exchange Offer is conditioned upon the satisfaction or waiver of the conditions set forth in the Offering Memorandum.
  • persons” as defined in Rule 902 under the Securities Act and in compliance with Regulation S under the Securities Act.

Bilibili Inc. Announces Completion of the Repurchase Right Offer for 1.375% Convertible Senior Notes due 2026

Retrieved on: 
Friday, March 29, 2024

SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced that it has completed its previously announced repurchase right offer relating to its 1.375% Convertible Senior Notes due 2026 (CUSIP No.

Key Points: 
  • SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced that it has completed its previously announced repurchase right offer relating to its 1.375% Convertible Senior Notes due 2026 (CUSIP No.
  • 090040AB2) (the “Notes”).
  • The repurchase right offer expired at 5:00 p.m., New York City time, on Thursday, March 28, 2024.
  • Based on information from Deutsche Bank Trust Company Americas as the paying agent for the Notes, US$429,331,000 aggregate principal amount of the Notes were validly surrendered and not withdrawn prior to the expiration of the repurchase right offer.

South Jersey Industries, Inc. Announces Results of Final Remarketing of Series B 1.65% Remarketable Junior Subordinated Notes due 2029

Retrieved on: 
Thursday, March 28, 2024

FOLSOM, N.J., March 29, 2024 /PR Newswire/ – South Jersey Industries, Inc. (“SJI” or the “Company”) announced today the unsuccessful final remarketing of its $2,795,000 principal amount of 2021 Series B 1.65% Remarketable Junior Subordinated Notes due 2029 (CUSIP No.

Key Points: 
  • FOLSOM, N.J., March 29, 2024 /PR Newswire/ – South Jersey Industries, Inc. (“SJI” or the “Company”) announced today the unsuccessful final remarketing of its $2,795,000 principal amount of 2021 Series B 1.65% Remarketable Junior Subordinated Notes due 2029 (CUSIP No.
  • 838518 AB4 / ISIN US838518AB47) (the “Notes”) that form a part of the outstanding Corporate Units (CUSIP No.
  • 838518 306 / ISIN US8385183061) issued by the Company on March 22, 2021.
  • The Company’s final remarketing period for the notes expired on March 28, 2024.

Rackspace Technology Announces Early Tender Results of the Exchange Offer Relating to its 3.50% First-Priority Senior Secured Notes due 2028

Retrieved on: 
Thursday, March 28, 2024

(2) Holders of Existing Secured Notes that are accepted for exchange pursuant to the Exchange Offer will be entitled to receive accrued and unpaid interest in cash on the Existing Secured Notes exchanged for Exchange Notes up to, but excluding, March 12, 2024.

Key Points: 
  • (2) Holders of Existing Secured Notes that are accepted for exchange pursuant to the Exchange Offer will be entitled to receive accrued and unpaid interest in cash on the Existing Secured Notes exchanged for Exchange Notes up to, but excluding, March 12, 2024.
  • Interest on the Exchange Notes will accrue from March 12, 2024, with the first interest payment occurring on August 15, 2024.
  • As of 5:00 p.m., New York City time, on March 28, 2024, the right to withdraw tenders of Existing Secured Notes expired.
  • Eligible holders who tender (and do not validly withdraw) all of their Existing Secured Notes after the Early Participation Time but at or prior to the Expiration Time, and their Existing Secured Notes are accepted, will receive the Late Exchange Consideration described above.

Robex Announces Share Consolidation

Retrieved on: 
Thursday, March 28, 2024

QUEBEC CITY, March 28, 2024 (GLOBE NEWSWIRE) -- Robex Resources Inc. ("Robex" or the "Company") (TSXV: RBX) announces today that its Board of Directors has approved the implementation of the consolidation of the issued and outstanding common shares of the Company approved by its shareholders on June 29, 2023, on the basis of one (1) post-consolidation common share for ten (10) pre-consolidation common shares (the "Consolidation"), which will take effect on April 1st, 2024 (the "Effective Date").

Key Points: 
  • NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
    QUEBEC CITY, March 28, 2024 (GLOBE NEWSWIRE) -- Robex Resources Inc. ("Robex" or the "Company") (TSXV: RBX) announces today that its Board of Directors has approved the implementation of the consolidation of the issued and outstanding common shares of the Company approved by its shareholders on June 29, 2023, on the basis of one (1) post-consolidation common share for ten (10) pre-consolidation common shares (the "Consolidation"), which will take effect on April 1st, 2024 (the "Effective Date").
  • After the Consolidation, the shares will have a new CUSIP number and a new ISIN number.
  • The Consolidation will reduce the number of issued and outstanding common shares of the Company from approximately 844,054,403 common shares to 84,405,449 common shares upon completion of the Consolidation.
  • No fractional common shares will be issued in connection with the Consolidation and all fractional common shares that would otherwise have been issued will be rounded to the nearest whole common share.

Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split

Retrieved on: 
Thursday, March 28, 2024

During the meeting, Cartesian stockholders approved the issuance of shares of common stock upon conversion of Cartesian’s Series A Non-Voting Convertible Preferred Stock.

Key Points: 
  • During the meeting, Cartesian stockholders approved the issuance of shares of common stock upon conversion of Cartesian’s Series A Non-Voting Convertible Preferred Stock.
  • In addition, stockholders voted to approve a reverse stock split of Cartesian’s issued and outstanding common stock.
  • The reverse stock split will reduce the number of issued and outstanding shares of the Company’s common stock from approximately 165.5 million shares to approximately 5.5 million shares before the automatic conversion of the Company’s Series A Non-Voting Convertible Preferred Stock into common stock, or approximately 17.8 million shares thereafter.
  • The approximately 166.3 thousand shares of Series A Non-Voting Convertible Preferred Stock that remain subject to beneficial ownership limitations will be convertible into approximately 5.5 million shares of common stock for a total of approximately 23.3 million shares of common stock outstanding once converted.

Pluri Inc. Announces 1-for-8 Reverse Share Split

Retrieved on: 
Wednesday, March 27, 2024

After giving effect to the reverse share split of the Company’s Common Shares, each eight (8) Common Shares will be combined into one Common Share, such that the Company’s 41,816,959 Common Shares outstanding will be reduced to approximately 5,227,120 Common Shares outstanding (the “Reverse Share Split”).

Key Points: 
  • After giving effect to the reverse share split of the Company’s Common Shares, each eight (8) Common Shares will be combined into one Common Share, such that the Company’s 41,816,959 Common Shares outstanding will be reduced to approximately 5,227,120 Common Shares outstanding (the “Reverse Share Split”).
  • No fractional shares will be issued as a result of the reverse split as any fractional shares resulting from the reverse split will be rounded up to the nearest whole share on a per shareholder basis.
  • No additional Company or shareholder approval is required because both the number of authorized Common Shares and the number of outstanding Common Shares will be proportionally reduced as a result of the Reverse Share Split, the Reverse Share Split will not adversely affect any other class of shares of the Company and the Company will not pay money or issue scrip to shareholders who would otherwise be entitled to receive a fractional share as a result of the reverse split.
  • The reverse split will not impact any shareholder's percentage ownership of Pluri or voting power, except for minimal effects resulting from the treatment of fractional shares.

Li Auto Inc. Announces Put Right Notification for 0.25% Convertible Senior Notes due 2028

Retrieved on: 
Wednesday, March 27, 2024

BEIJING, March 27, 2024 (GLOBE NEWSWIRE) -- Li Auto Inc. (the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it is notifying holders of its 0.25% Convertible Senior Notes due 2028 (CUSIP No.

Key Points: 
  • BEIJING, March 27, 2024 (GLOBE NEWSWIRE) -- Li Auto Inc. (the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it is notifying holders of its 0.25% Convertible Senior Notes due 2028 (CUSIP No.
  • The Put Right expires at 5:00 p.m., New York City time, on Monday, April 29, 2024.
  • The 2024 Repurchase Date is an interest payment date under the terms of the Indenture and the Notes.
  • Holders of Notes may request the Company’s Put Right Notice from the paying agent, Deutsche Bank Trust Company Americas.

Tidal and Hashdex Announce Trading of U.S. Spot Bitcoin ETF

Retrieved on: 
Tuesday, March 26, 2024

NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- Tidal Investments LLC (“Tidal” or the “Sponsor”), a leading name in the ETF industry, and Hashdex Asset Management Ltd. (“Hashdex”), a leading global crypto-focused asset manager, today announced the renaming of the Hashdex Bitcoin Futures ETF to the Hashdex Bitcoin ETF ("DEFI” or “Fund”) (Ticker NYSE Arca: DEFI, CUSIP: 88634V100).

Key Points: 
  • NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- Tidal Investments LLC (“Tidal” or the “Sponsor”), a leading name in the ETF industry, and Hashdex Asset Management Ltd. (“Hashdex”), a leading global crypto-focused asset manager, today announced the renaming of the Hashdex Bitcoin Futures ETF to the Hashdex Bitcoin ETF ("DEFI” or “Fund”) (Ticker NYSE Arca: DEFI, CUSIP: 88634V100).
  • Tidal ETF Services LLC serves as the Fund’s Administrator and BitGo serves as its Bitcoin Custodian.
  • The completed conversion of the Fund to a spot bitcoin ETF allows investors to gain exposure to spot pricing through an established product.
  • “We chose to partner with Hashdex on the Hashdex Bitcoin ETF because we knew that the firm’s extensive experience in the space would ensure that we custom-built an investor-friendly product that can offer benefits that otherwise may be unavailable when trading bitcoin directly in unregulated markets,” said Mike Venuto, CIO and Co-Founder of Tidal.

Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics

Retrieved on: 
Tuesday, March 26, 2024

The combined company will operate under the name Serina Therapeutics and will trade on the NYSE American market under the ticker symbol “SER” effective with the open of business on Wednesday, March 27, 2024.

Key Points: 
  • The combined company will operate under the name Serina Therapeutics and will trade on the NYSE American market under the ticker symbol “SER” effective with the open of business on Wednesday, March 27, 2024.
  • The new CUSIP number for the combined company following the merger is 81751A108.
  • Serina Board Chair J. Milton Harris, Ph.D., stated, “This merger is the culmination of years of work on the part of the Serina team and enables us to move our lead polyoxazoline-drug conjugate into clinical trials.
  • Bradley Arant Boult Cummings LLP provided legal counsel to Serina.